Adler Eric
Chief Medical Officer
Adler Eric has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Nov 20, 2025.
On the most recent filing, Adler Eric is listed as Chief Medical Officer at Lexeo Therapeutics, Inc. Inside the rolling window, Adler Eric reported no open-market purchases and 2 open-market sales totaling $36K in LXEO. The largest disclosed transaction in the window is a sale of 3,382 LXEO shares on Oct 17, 2025, worth $30K.
Companies traded
Other insiders at LXEO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$36K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Adler Eric made?
Adler Eric has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Adler Eric trade?
Adler Eric has filed SEC Form 4 disclosures for 1 company, including LXEO.
When was Adler Eric's most recent SEC Form 4 filing?
Adler Eric's most recent SEC Form 4 filing on Tracefour is dated Nov 20, 2025.
What is Adler Eric's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Adler Eric is listed as Chief Medical Officer.
What is Adler Eric's total buy and sell value in the current window?
Inside the rolling retention window, Adler Eric bought $0 and sold $36K based on SEC Form 4 filings.
What was Adler Eric's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,382 LXEO shares on 2025-10-17, worth $30K, per SEC Form 4 filings.